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Previous studies have provided extensive evidence that adminis-
tration of cannabinoid drugs after training modulates the con-
solidation of memory for an aversive experience. The present
experiments investigated whether the memory consolidation is
regulated by endogenously released cannabinoids. The experi-
ments first examined whether the endocannabinoids anandamide
(AEA) and 2-arachidonoyl glycerol (2-AG) are released by aversive
training. Inhibitory avoidance training with higher footshock
intensity produced increased levels of AEA in the amygdala,
hippocampus, and medial prefrontal cortex (mPFC) shortly after
training in comparison with levels assessed in rats trained with
lower footshock intensity or unshocked controls exposed only to
the training apparatus. In contrast, 2-AG levels were not signifi-
cantly elevated. The additional finding that posttraining infusions
of the fatty acid amide hydrolase (FAAH) inhibitor URB597, which
selectively increases AEA levels at active synapses, administered into
the basolateral complex of the amygdala (BLA), hippocampus, ormPFC
enhanced memory strongly suggests that the endogenously released
AEA modulates memory consolidation. Moreover, in support of the
view that this emotional training-associated increase in endocannabi-
noid neurotransmission, and its effects on memory enhancement,
depends on the integrity of functional interactions between these
different brain regions, we found that disruption of BLA activity
blocked the training-induced increases in AEA levels as well as the
memory enhancement produced by URB597 administered into the
hippocampus or mPFC. Thus, the findings provide evidence that
emotionally arousing training increases AEA levels within prefrontal-
limbic circuits and strongly suggest that this cannabinoid activation
regulates emotional arousal effects on memory consolidation.
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It is well-established that stressful or emotionally arousingexperiences are well-remembered (1). In addition, there is
extensive evidence that the basolateral complex of the amygdala
(BLA), hippocampus, and medial prefrontal cortex (mPFC) are
all crucially involved in mediating emotional arousal effects on
memory consolidation (2, 3). The consolidation of memories of
arousing experiences requires an orchestration of neural activity in
these brain systems, and the cannabinoid system has emerged as
a key modulator of such function (1, 4–6). Endogenous cannabi-
noid ligands [termed endocannabinoids, mainly N-arachidonoyl
ethanolamine (anandamide; AEA) and 2-arachidonoyl glycerol
(2-AG)] are released from postsynaptic membranes and feed-
back in a retrograde manner onto either excitatory or inhibitory
presynaptic terminals, thus suppressing both excitatory and in-
hibitory signaling within specific neuronal circuits (7).
Extensive evidence indicates that exogenous cannabinoids ad-
ministered into this neural circuitry modulate memory processing
of emotionally arousing training (8–12). We previously showed
that the synthetic cannabinoid agonist WIN55,212-2, administered
into the BLA immediately after inhibitory avoidance training,
enhances the consolidation of long-term memory (8). Conversely,
inhibition of endogenous cannabinoid signaling within the BLA
with posttraining infusions of the cannabinoid type 1 (CB1) re-
ceptor antagonist AM251 impairs inhibitory avoidance memory
(8). We recently reported that the level of emotional arousal at the
time of training is an important factor in determining cannabinoid
effects on memory (13): WIN55,212-2 administration enhanced
long-term object recognition memory when rats were trained un-
der a high arousal condition but was ineffective with low-arousing
training (13). Although the findings of our prior studies, as well as
those of other investigators (6, 8, 11–13), indicate that adminis-
tration of cannabinoids can modulate memory consolidation,
studies have not yet investigated whether AEA or 2-AG are re-
leased physiologically in response to emotionally arousing training
and normally play a role in creating strong memories for these
experiences. The present experiments investigated this issue. Rats
were trained on an inhibitory avoidance task under different
arousal conditions and were killed after training for determination
of AEA and 2-AG levels in the amygdala, hippocampus, and
mPFC. To investigate whether training-induced endocannabinoid
release contributes to memory consolidation, we pharmacologically
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blocked AEA degradation in the BLA, hippocampus, or mPFC by
locally infusing the fatty acid amide hydrolase (FAAH) inhibitor
URB597 immediately after inhibitory avoidance training. In
contrast to direct cannabinoid receptor agonists, URB597 selec-
tively augments AEA signaling at active synapses, thus mimick-
ing the physiological condition normally occurring after an emo-
tionally arousing training experience.
The experiments also investigated whether training-associated
endocannabinoid neurotransmission within this neurocircuitry
depends on functional interactions between the BLA, hippo-
campus, and mPFC. Extensive evidence indicates that the BLA
contributes to enhancement of memory for emotional events
primarily by integrating neuromodulatory influences and mod-
ulating neural activity and synaptic plasticity in other brain
regions (1). The BLA is known to project both directly and in-
directly to the hippocampus (14, 15) and mPFC (16, 17), and it
has been shown that a disruption of BLA activity blocks the
memory-enhancing effects of drugs administered directly into
either the hippocampus or mPFC (18, 19). Therefore, in this last
series of experiments, we investigated whether an intact BLA ac-
tivity is required to allow for a normal endocannabinoid response in
the hippocampus and mPFC after an aversive training experience.
Results
Aversive Inhibitory Avoidance Training Increases AEA Levels Within
the Amygdala, Hippocampus, and mPFC. This experiment inves-
tigated whether inhibitory avoidance training elevates AEA and
2-AG levels within the amygdala, hippocampus, and mPFC, and
whether the magnitude of the effects depends on the aversive-
ness of the training procedure. Rats were trained on an in-
hibitory avoidance task with either a lower (0.35-mA; lower FS)
or higher footshock intensity (0.45-mA; higher FS) or were ex-
posed to the experimental apparatus without any footshock (no
FS). Fig. 1 shows that these two FS intensities resulted in dif-
ferent 48-h retention latencies (F2,17 = 20.41; P < 0.0001). For
endocannabinoid measurements, rats were killed 10, 30, or 60
min after training. Our findings indicate that the more aversive
training condition elevated AEA, but not 2-AG, levels in all
three brain regions. As shown in Fig. 2A, two-way ANOVA for
amygdala AEA levels revealed a significant FS condition effect
(F2,50 = 16.92; P < 0.0001) but no time effect (F2,50 = 0.003; P =
0.99) or interaction between both factors (F4,50 = 0.40; P = 0.81).
Post hoc tests indicated that the higher FS significantly increased
amygdala AEA levels at 10, 30, and 60 min after the training trial
compared with rats given the lower FS (30 min: P < 0.05; 10 and
60 min: P < 0.01) or those unshocked (10 and 30 min: P < 0.05;
60 min: P < 0.01). As shown in Fig. 2B, two-way ANOVA for
AEA levels in the hippocampus revealed a significant FS con-
dition effect (F2,44 = 14.25; P < 0.0001), no time effect (F2,44 =
1.27; P = 0.29), and a significant interaction between both factors
(F4,44 = 2.73; P = 0.04). Post hoc tests indicated that the higher
FS significantly increased hippocampal AEA levels 10 min after
the training trial compared with the unshocked controls (P <
0.01). Two-way ANOVA for AEA levels in the mPFC revealed
a significant FS condition effect (F2,49 = 5.47; P < 0.007) but no
time effect (F2,49 = 2.94; P = 0.06) or interaction between both
factors (F4,49 = 1.54; P = 0.20; Fig. 2C). Post hoc tests indicated
that the higher FS significantly increased AEA levels in the
mPFC 60 min after the training trial compared with unshocked
rats (P < 0.05; Fig. 2C). Rats exposed to the lower FS did not
differ in AEA levels compared with unshocked rats in the three
brain areas at any time point. Inhibitory avoidance training did
not affect 2-AG levels in any of the brain regions at any time
point (SI Results and Table S1). In plasma, AEA levels were
significantly elevated 60 min after inhibitory avoidance training
with the higher, but not lower, FS (SI Results and Table S2).
Posttraining Infusions of the FAAH Inhibitor URB597 into the BLA,
Hippocampus, and mPFC Enhance Inhibitory Avoidance Memory via
Indirect Activation of CB1 Receptors. To determine whether the
elevated AEA levels induced by the higher FS contribute to the
enhancement of memory of this more aversive training experi-
ence, we next investigated whether exogenous augmentation of
training-induced AEA levels with posttraining infusions of the
FAAH inhibitor URB597 into the BLA, hippocampus, or mPFC
modulates memory consolidation. Our findings indicate that
URB597 administered into all three brain regions enhances mem-
ory consolidation.
As shown in Fig. 3A, 48-h retention latencies of rats admin-
istered vehicle into the BLA immediately after training were
significantly longer than their entrance latencies during the
training trial (t11 = −3.63; P = 0.004), indicating that the rats
retained memory of the shock experience. Posttraining URB597
into the BLA enhanced 48-h retention latencies in an inverted
U-shape relationship (F3,46 = 3.63; P = 0.02). Post hoc tests in-
dicated that the 10-ng dose of URB597 produced retention la-
tencies that were significantly longer than those of rats given
vehicle (P < 0.05). Lower or higher doses (3 or 30 ng) were in-
effective. Fig. 3B shows that URB597 infused posttraining into
the hippocampus also enhanced 48-h retention latencies (F3,32 =
3.30; P = 0.03). Post hoc tests indicated that the 10-ng dose of
URB597 significantly enhanced retention performance (P <
0.05), with lower or higher doses (3 or 30 ng) being ineffective.
Fig. 3C shows that URB597 infusions into the mPFC also en-
hanced 48-h retention latencies (F3,48 = 3.97; P = 0.01). Post hoc
comparisons indicated that the 30-ng dose of URB597 signifi-
cantly enhanced retention performance (P < 0.05). Lower doses
(3 or 10 ng) were ineffective.
Next, we examined whether the elevated AEA levels, induced
by URB597 administration, enhance memory consolidation via an
activation of CB1 receptors. Rats were administered the effective
dose of URB597 together with a nonimpairing dose of the CB1
receptor antagonist AM251 immediately after the training trial.
Our findings indicate that the URB597 effect on memory con-
solidation depends on CB1 receptor activity in all three brain
regions investigated. Fig. 3D shows 48-h retention test latencies of
rats administered URB597 together with AM251 into the BLA.
Two-way ANOVA for retention latencies revealed a significant
URB597 effect (F1,34 = 4.27; P = 0.04), a significant AM251 effect
(F1,34 = 5.47; P = 0.03), and a significant interaction between both
factors (F1,34 = 5.45; P = 0.03). Post hoc tests indicated that
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Fig. 1. Effect of different levels of emotional arousal on inhibitory avoid-
ance memory. (A) Step-through latencies during inhibitory avoidance
training of rats trained under three different conditions (only exposed to the
context without receiving any FS, no FS; with a lower FS intensity, lower FS;
with a higher FS intensity, higher FS). (B) Step-through latencies on a 48-h
retention test. The increase of FS intensity during the training trial enhanced
memory consolidation of the inhibitory avoidance task. *P < 0.05, **P < 0.01
vs. the no FS group; ♦P < 0.05 vs. the lower FS group. Results represent
mean ± SEM (n = 6–7 per group).
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retention latencies of rats given URB597 (10 ng) were significantly
longer than those of rats given vehicle (P < 0.05). Retention la-
tencies of rats given a nonimpairing dose of AM251 (0.14 ng)
together with URB597 were significantly shorter than those of rats
treated with URB597 alone (P < 0.05). Fig. 3E shows 48-h re-
tention latencies of rats given URB597 and AM251 into the
hippocampus. Two-way ANOVA for retention latencies revealed
a significant URB597 effect (F1,47 = 8.42; P = 0.006), a significant
AM251 effect (F1,47 = 11.13; P = 0.002), and a significant in-
teraction between both factors (F1,47 = 10.74; P = 0.002). Post
hoc comparisons indicated that retention latencies of rats given
URB597 (10 ng) were significantly longer than those of vehicle-
treated rats (P < 0.01). Retention latencies of rats given a non-
impairing dose of AM251 (0.28 ng) together with URB597 were
significantly shorter than those of rats treated with URB597 alone
(P < 0.01). Fig. 3F shows 48-h retention latencies of rats admin-
istered URB597 and AM251 into the mPFC. Two-way ANOVA
revealed a significant URB597 effect (F1,38 = 5.58; P = 0.03), no
AM251 effect (F1,38= 3.87; P = 0.06), and a significant interaction
between both factors (F1,38 = 4.41; P = 0.04). Post hoc compar-
isons indicated that retention latencies of rats given URB597
(30 ng) were significantly longer than those of rats given vehicle
(P < 0.05). Retention latencies of rats given a nonimpairing dose
of AM251 (0.28 ng) together with URB597 were significantly
shorter than those of rats treated with URB597 alone (P < 0.05).
An Intact BLA Is Required for Enabling the Training-Induced Increase of
AEA Levels Within the Hippocampus and mPFC. It is well-established
that prefrontal-limbic circuits regulate emotional arousal effects
on memory consolidation. In this experiment, we investigated
whether functional interactions between the BLA, hippocampus,
and mPFC are necessary for modulating endocannabinoid activity
in response to an aversive training experience. We made bilateral
excitotoxic lesions of the BLA and subsequently measured AEA
and 2-AG levels in the hippocampus and mPFC after inhibitory
avoidance training. Rats were trained with the higher FS and killed
10 or 60 min later for hippocampus and mPFC dissection (in the
previous experiments, we found that AEA levels in the hippo-
campus and mPFC were elevated 10 and 60 min after training,
respectively; Fig. 2 B and C). As shown in Fig. 4 A and B, bilateral
BLA lesions abolished the training-induced increases in AEA levels
in both the hippocampus and mPFC (hippocampus: t9 = 7.11;
P < 0.0001; mPFC: t11 = 2.79; P = 0.02). Bilateral BLA lesions
did not affect 2-AG levels in either the hippocampus or mPFC
after inhibitory avoidance training (t9 = 0.41; P = 0.69; t11 =
−0.12; P = 0.91, respectively; Table S3). These findings in-
dicate that an intact BLA is necessary for inducing a training-
associated increase of AEA levels within the hippocampus
and mPFC, and provide important support for the view that
functional interactions between these brain regions are re-
quired to coordinate endocannabinoid responses after emo-
tionally arousing training.
An Intact BLA Is Required for Enabling the Memory-Enhancing Effect
of Posttraining URB597 Infusions into the Hippocampus and mPFC. To
further investigate the significance of functional interactions
between these brain regions in regulating endocannabinoid
effects on memory consolidation, we examined whether an intact
BLA is also required for enabling the memory-enhancing effect
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Fig. 2. Effect of the level of emotional arousal of an inhibitory avoidance training trial on AEA levels in the amygdala, hippocampus, and mPFC, measured at
different time points after the training. The higher FS condition induced an increase in AEA levels in the amygdala (A) at 10, 30, and 60 min after the training,
in the hippocampus (B) at 10 min after the training, and in the mPFC (C) at 60 min after the training. *P < 0.05, **P < 0.01 vs. the corresponding no FS group;
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Fig. 3. Effects of intra-BLA, intrahippocampus, or intra-mPFC infusions of
the FAAH inhibitor URB597, either alone or together with the CB1 receptor
antagonist AM251, on 48-h retention. Immediate posttraining bilateral
infusions of URB597 (URB; 3, 10, or 30 ng) into the BLA (A), hippocampus (B),
or mPFC (C) enhanced memory consolidation. Concurrent administration of
a nonimpairing dose of AM251 (0.14–0.28 ng per side) blocked the memory-
enhancing effects of URB597 (10 or 30 ng) in the BLA (D), hippocampus (E),
or mPFC (F). Representative photomicrographs (Nikon 801 microscope;
original magnification 2×) illustrating the placement of the cannula and
needle tip in the BLA (G), hippocampus (H), and mPFC (I). *P < 0.05, **P < 0.01
vs. the corresponding vehicle (Veh) group; ♦P < 0.05, ♦♦P < 0.01 vs. the cor-
responding AM251 group. Results represent mean ± SEM (n = 8–13 per group).
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of URB597 when infused into either the hippocampus or mPFC.
Concerning the hippocampus, two-way ANOVA for training
latencies revealed no BLA lesion effect (F1,46 = 1.46; P = 0.23)
and no difference between later drug treatment groups (F1,46 =
0.28; P = 0.60) or interaction between both factors (F1,46 = 0.68;
P = 0.41). Two-way ANOVA for 48-h retention latencies
revealed a significant BLA lesion effect (F1,46 = 12.10; P =
0.001), a significant URB597 effect (F1,46 = 4.12; P = 0.048), and
a significant interaction between these two factors (F1,46 = 4.84;
P = 0.03). As shown in Fig. 4C, URB597 (10 ng) infused into the
hippocampus of sham-lesioned rats enhanced 48-h retention
relative to their corresponding vehicle group (P < 0.05). Further-
more, and importantly, BLA lesions blocked the memory-enhancing
effect of URB597 infused into the hippocampus (P < 0.01).
Next, we examined URB597 effects in the mPFC. Two-way
ANOVA for training latencies revealed no BLA lesion effect
(F1,41 = 1.99; P = 0.17) and no difference between later drug
treatment groups (F1,41 = 1.04; P = 0.31) or interaction between
both factors (F1,41 = 0.46; P = 0.50). Two-way ANOVA for 48-h
retention test latencies revealed a significant BLA lesion effect
(F1,41 = 11.80; P = 0.001), a significant URB597 effect (F1,41 =
6.26; P = 0.02), and a significant interaction between these two
factors (F1,41 = 4.91; P = 0.03). As shown in Fig. 4D, post hoc
tests indicated that URB597 (30 ng) infused into the mPFC of
sham-lesioned rats enhanced 48-h retention compared with the
vehicle group (P < 0.05). BLA lesions blocked the memory-
enhancing effect of URB597 infused into the mPFC (P < 0.01).
Thus, our findings indicate that the BLA is critically involved in
regulating the memory-enhancing effects of endocannabinoids in
the hippocampus and mPFC.
Discussion
The present findings indicate that a dynamic network involving
AEA signaling within the BLA, hippocampus, and mPFC mod-
ulates the consolidation of memory for emotionally arousing
training. Moreover, our results suggest that the BLA plays a
crucial role in coordinating hippocampal and mPFC endocanna-
binoid activity within this neurocircuitry during the consolidation
of memories for aversive experiences.
Rats trained under a higher arousal condition retained better
memory of the aversive event than did rats trained under a lower
arousal condition, and this effect was paralleled by an increase in
AEA levels within the amygdala, hippocampus, and mPFC. In
contrast, 2-AG levels were unaffected. The increase in AEA
content showed a temporal-dependent response during the early
phases of memory consolidation, with a sustained increase of
AEA levels in the amygdala (from 10 to 60 min after training)
and an increase only at 10 and 60 min after training in the
hippocampus and mPFC, respectively. The increase of AEA
signaling induced by posttraining administration of the FAAH
inhibitor URB597 enhanced 48-h inhibitory avoidance reten-
tion performance through indirect activation of CB1 receptors.
Additionally, we found that this training-induced increase in
endocannabinoid neurotransmission depends on the integrity of
functional interactions between these brain regions, because
disruption of BLA activity resulted in a loss of the training-
induced AEA response as well as the URB597 effect in the hip-
pocampus and mPFC.
It is well-known that CB1 receptors, highly expressed throughout
the limbic system (20), modulate neuronal signaling and synaptic
plasticity (21, 22), thereby regulating emotional behavior and
memory processes activated by emotionally arousing events (8, 9,
23–26). However, studies have reported conflicting findings con-
cerning cannabinoid effects on memory consolidation (for a review,
see ref. 6). Cannabinoid effects on memory are highly dependent
on the level of emotional arousal induced by the stressfulness of
the experimental condition used in the different studies (6, 13, 27).
Our findings are consistent with prior evidence in indicating that
inhibitory avoidance training induces the release of the endo-
cannabinoid AEA in the amygdala, hippocampus, and mPFC only
under highly aversive conditions. This endocannabinoid response
was not detectable when animals received a lower FS.
To investigate whether the endogenous release of AEA after
inhibitory avoidance training is linked to the stabilization of the
memory trace, we tested whether pharmacological amplification
of AEA signaling would affect memory consolidation for in-
hibitory avoidance training. Our findings indicate that the FAAH
inhibitor URB597, which increases endogenous AEA levels in
the synaptic cleft (28), enhanced 48-h retention when infused
into the BLA, hippocampus, or mPFC after training. URB597
also affects, to a certain extent, the hydrolysis of other fatty-acid
ethanolamides that do not bind to CB1 receptors. Our result that
the URB597 effect was blocked by concurrent administration of
the CB1 receptor antagonist AM251 indicates that the URB597-
induced memory enhancement involves an increase in AEA
signaling and activation of CB1 receptors. Our findings are, thus,
consistent with previous evidence indicating that a blockade of
endocannabinoid neurotransmission in the hippocampus (29),
amygdala (30), and mPFC (12) impairs the consolidation of aver-
sively motivated training experiences.
We previously reported that endocannabinoid effects on
memory consolidation depend on the level of emotional arousal
at the time of encoding (6, 13, 27). Such findings suggest that an
interaction with stress hormones is important in determining the
modulatory effects of cannabinoids on memory processes. The
BLA is known to influence the association of environmental
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information with emotional significance by engaging stress-
related hormones and neurotransmitters to modulate memory
processes (31, 32). We have previously shown that intra-BLA
administration of the CB1 receptor antagonist AM251 blocks the
ability of systemically administered corticosterone to facilitate
the consolidation of memory of inhibitory avoidance training (8).
Such findings indicate that glucocorticoids recruit endocanna-
binoid signaling in the BLA to modulate memory consolidation
(33, 34). Our current results add to this evidence the findings
that, after a stressful event, the endogenous release of AEA in
prefrontal-limbic areas enhances memory consolidation for aver-
sive experiences via an activation of CB1 receptors. Findings in the
literature indicate a direct correlation between FS intensity and
norepinephrine release in the amygdala (35). Therefore, it is likely
that a certain degree of emotional arousal, induced by the higher
FS intensity, leads to an optimal activation of stress mediators that
is necessary to recruit the endocannabinoid system and, ultimately,
mediate the formation of a strong memory trace.
Considerable evidence indicates that the BLA modulates
memory consolidation by coordinating the activation of other
brain regions and by regulating memory processes that take
place elsewhere in the brain (1, 31, 36–38). This modulation
might involve either direct or indirect neural connections to
various limbic structures, including the hippocampus and
mPFC (14, 15, 39, 40). Our findings provide additional evi-
dence supporting this implication in indicating that a functional
BLA is required to enable the modulatory effect of AEA within
the hippocampus and mPFC on memory consolidation. These
findings are also consistent with evidence that interactions of
the BLA with the hippocampus (18, 41, 42) and mPFC (19)
regulate emotional arousal effects on memory consolidation.
Our findings further indicate that, depending on the brain re-
gion, AEA increases with distinct temporal windows during
early phases of memory consolidation. We show that activation
of the BLA regulates the endocannabinoid response in the
hippocampus and mPFC, as permanent lesions of the BLA
blocked the training-induced increase of AEA levels and the
memory-enhancing effects of URB597 in both the hippocampus
and mPFC.
Previous findings suggest that the initiation of a strong emo-
tional experience activates memory-related neuroplasticity in the
amygdala and hippocampus whereas suppressing PFC function-
ing (43). Such a model suggests a rapid activation of the BLA
and hippocampus after a stressful experience, followed by an
inhibitory phase. Moreover, there is evidence that corticosterone
rapidly but transiently enhances the frequency of miniature
postsynaptic currents (mEPSCs) in the hippocampal CA1 area
(44), whereas it also rapidly increases mEPSCs in the BLA, but
over a longer time window (45). Accordingly, we found a rapid
and transient increase of AEA levels in the hippocampus and
a rapid but enduring increase within the amygdala. It is well-
accepted that CB1 receptor activation mediates a decrease in
GABA release in the BLA (46). Thus, the rapid increase in
amygdala AEA content observed in our study may represent one
of the most rapid actions of BLA activation after experiencing an
aversive event. In particular, the AEA-mediated activation of
CB1 receptors in the BLA may decrease feedforward inhibition
via inhibitory interneurons, thereby increasing the activity of
BLA projection neurons (47). On the other hand, basal mPFC
activity is known to provide an inhibitory influence on BLA ac-
tivity (16, 48), whereas stress and glucocorticoids are known to
suppress mPFC functions (49). It has previously been reported
that glucocorticoid infusions into the mPFC enhance memory
consolidation of an inhibitory avoidance training via functional
and bidirectional interactions with the BLA (19). Thus, the
present findings provide additional evidence that increased BLA
activation during emotionally arousing conditions (38, 49, 50)
enhances the consolidation of different kinds of information via
its projections to other brain regions.
Considered together, our findings indicate that, as a response
to emotional events, endocannabinoids are released within the
prefrontal-limbic neurocircuitry, where they enhance the con-
solidation of memory for emotionally arousing events. These
findings are of crucial importance, helping to understand the
neural underpinnings of the temporal interactions between limbic
regions after experiencing a stressful event and shedding light on
the neural mechanism involved in the process of aversive memory
formation.
Materials and Methods
Animals. Male Sprague–Dawley rats (320–370 g at the time of behavioral
experiments; Charles River) were housed individually in a temperature-controlled
(20 ± 1 °C) vivarium room and maintained under a 12-h/12-h light/dark cycle
(7:00 AM to 7:00 PM lights on). Food and water were available ad libitum. All
procedures were in compliance with Italian law (D.L. 26/14), a European Union
directive (2010/63/EU), the Declaration of Helsinki, and Guidelines for the Care
and Use of Mammals in Neuroscience and Behavioral Research (51).
Surgery. Rats were anesthetized with sodium pentobarbital (50 mg/kg, i.p.),
given atropine sulfate (0.4 mg/kg, i.p.) to maintain respiration, and sub-
sequently injectedwith 3mL of saline (s.c.) to facilitate clearance of drugs and
prevent dehydration. The rats were then placed in a stereotaxic frame (Kopf
Instruments), and two stainless-steel guide cannulae (23-gauge) were
implanted bilaterally, with the cannula tips 2 mm above the BLA [15 mm;
coordinates: anteroposterior (AP), −2.8 mm from Bregma; mediolateral (ML),
±5.0 mm from midline; dorsoventral (DV), −6.5 mm from skull surface] or
1.5 mm above the CA1 region of the dorsal hippocampus [11 mm; coor-
dinates: AP, −3.4 mm; ML, ±1.8 mm; DV, −2.7 mm] or the prelimbic region of
the mPFC [11 mm; coordinates: AP, +3.7 mm; ML, ±0.7 mm; DV, −2.4 mm]
(19, 52, 53). Stylets (15- or 11-mm-long 00 insect dissection pins) were
inserted into each cannula to maintain patency.
The NMDA solution (Sigma-Aldrich; 2.5 μg in 0.2 μL of phosphate buffer)
was backfilled into a 10-μL Hamilton microsyringe (30-gauge) driven by a ste-
reotaxic minipump (Stoelting) and infused into the BLA over a 30-s period (54).
The needle was retained in place for an additional 3 min to optimize diffusion.
Rats were allowed to recover from surgery for 10 d before training and
handled three times for 1 min before training.
Inhibitory Avoidance Apparatus and Experimental Procedures. Rats were
trained in an inhibitory avoidance apparatus (for details, see SI Materials and
Methods and ref. 8). Nonoperated rats were placed in the starting com-
partment and allowed to freely explore the apparatus. After the rat stepped
into the dark (shock) compartment, the sliding door was closed and a single
inescapable FS with an intensity of either 0.35 mA (lower FS) or 0.45 mA
(higher FS) was delivered for 1 s. Other rats were unshocked (no FS) upon
entering the dark compartment. Cannulated rats received higher FS in-
tensities (0.45–0.85 mA) to ensure memory in all experimental groups. Rats
were removed from the shock compartment 15 s later and returned to their
home cages. Some groups of rats were killed at 10, 30, or 60 min after the
training trial for endocannabinoid detection. Others were left undisturbed
and tested for retention 48 h later. For retention testing, the rat was placed
into the starting compartment and the latency to reenter the shock com-
partment with all four paws was measured (maximum latency of 600 s).
Longer latencies indicate better retention.
Drug Treatment. URB597 (Tocris; 3, 10, or 30 ng) was infused posttraining into
the BLA, hippocampus, or mPFC. To examine whether the URB597 effect was
mediated by activation of CB1 receptors, other groups of rats received the
effective dose of URB597 (10 ng BLA and hippocampus, 30 ng mPFC) concur-
rently with a nonimpairing dose of the CB1 receptor antagonist AM251 [Tocris;
0.14 ng for BLA (8), 0.28 ng for hippocampus and mPFC]. Doses were based on
pilot experiments performed in our laboratory. Bilateral sham- or BLA-lesioned
rats were administered the effective dose of URB597 into either the hippo-
campus or mPFC. Drugs were dissolved in 5% (vol/vol) PEG, 5% (vol/vol) Tween
80, and 90% (vol/vol) saline. The infusion procedure is detailed in SI Materials
and Methods.
Histology. Rats were anesthetized with an overdose of sodium pento-
barbital (100 mg/kg, i.p.) and perfused transcardially with 0.9% saline.
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The brains were removed to verify cannula placement and the size and
location of lesions (for details, see SI Materials and Methods).
Endocannabinoid Measurement. At 10, 30, or 60 min after inhibitory avoidance
training (no FS, lower FS, or higher FS), ratsweredecapitatedand theamygdala,
hippocampus, and mPFC were rapidly dissected for AEA and 2-AG measure-
ment (55).
Statistics. Data are expressed as mean ± SEM. Inhibitory avoidance latencies
as well as endocannabinoid levels were analyzed with one- or two-way
ANOVAs. The source of the detected significances was determined by
Tukey–Kramer post hoc tests. P values of less than 0.05 were considered
statistically significant. The number of rats per group is indicated in the
figure legends.
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